Sanofi and Regeneron's Dupixent gets more positive feedback from US FDA: companies

ประเทศไทย ข่าว ข่าว

The U.S. Food & Drug Administration (FDA) regulator gave more positive feedback on the Dupixent eczema treatment being developed by drugmakers ...